ReliefBand Technologies designs and develops digital wearable devices that provide therapies for nausea and morning sickness.
ReliefBand Technologies designs and develops digital wearable devices that provide therapies for nausea and morning sickness associated with motion, morning, chemotherapy, and as an adjunct to post-op nausea. Its therapeutic device offers a clinically proven, FDA cleared wearable technology for the treatment of nausea and vomiting associated with motion sickness, morning sickness, and VR Gaming chemotherapy and as an adjunct to post-op nausea, and offers pre-programmed pulses with specific waveform, frequency, and intensity of stimulation for the median nerve on the underside of the wrist, that enable users to treat nausea and vomiting in a drug-free manner by just wearing a wristband.ReliefBand Technologies was established in 2015 and is headquartered in Horsham, Pennsylvania.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 15, 2015 | Series Unknown | $5M | 1 | PathoCapital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
PathoCapital | Yes | Series Unknown |